Effect Of Laparoscopic Sleeve Gastrectomy on Vitamin D, Parathormone and Calcium Levels
1 other identifier
interventional
40
1 country
1
Brief Summary
Obesity is likely to be the disease of the 21th century. The growth of obesity is worldwide, a pandemic, and has increased globally in the last 30 years. Developed countries were more affected, but developing countries have increasingly contributed to this epidemic as they continue to modernize. The national and global burden of obesity, with its public health and financial implications, is projected to increase markedly in the next two decades. the study aimed to assess the effect of Vit D supplementation on preventing altered levels of calcium, Vit D, and parathormone after laparoscopic sleeve gastrectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 18, 2022
CompletedFirst Posted
Study publicly available on registry
June 24, 2022
CompletedAugust 5, 2022
August 1, 2022
2.1 years
June 18, 2022
August 3, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Vitamin D level assessment
Assessment of the vitamin D level after sleeve gastrectomy.
1 year
Study Arms (1)
Laparoscopic sleeve gastrectomy
EXPERIMENTALAfter sleeve gastrectomy, assessment of vitamin D, calcium and parathormone levels is performed.
Interventions
Laparoscopic resection of a part of the stomach to enable the patient to lose weight.
Eligibility Criteria
You may qualify if:
- Adult
- male or female
- from 18 to 60 ages
- BMI: 40 kg/m2 or \> 35 kg/m2
- comorbidities e.g., hypertension and DM
- conservative management for obesity failed in at least 2 years
You may not qualify if:
- BMI \> 60
- history of bariatric surgery
- symptomatic reflux oesophagitis
- stomach cancer
- active peptic ulcer disease
- alcohol or drug abuse
- major psychological disturbance
- major eating troubles
- risky anesthesia
- risky surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kafrelsheikh University
Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr, assistant lecturer of General Surgery
Study Record Dates
First Submitted
June 18, 2022
First Posted
June 24, 2022
Study Start
October 1, 2018
Primary Completion
November 1, 2020
Study Completion
December 1, 2020
Last Updated
August 5, 2022
Record last verified: 2022-08